Aviir Secures $3,000,000 New Funding

  • Feed Type
  • Date
    6/22/2011
  • Company Name
    Aviir
  • Mailing Address
    2463 Faber Place Palo Alto, CA 94303
  • Company Description
    Aviir is a venture-funded biotechnology company developing cutting-edge, convenient diagnostic tests enabling accurate diagnosis and prognosis of cardiovascular disease. The company’s proprietary technology draws on years of research at Stanford University, and combines the scientific founders’ deep understanding of disease marker proteins and advanced biostatistics. Aviir is pursuing an aggressive commercialization strategy, with initial products expected to reach the market in 2008.
  • Website
    http://www.aviir.com
  • Transaction Type
    Debt, Venture Equity
  • Transaction Amount
    $3,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. Amount may include options, warrants or other rights to acquire other securities. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy